Rexahn Pharmaceuticals Inc

-

Stock Issuer and Owners

Home | Sign Up | Log In
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Rexahn Pharmaceuticals Inc
TickerOCUP
CIK #0001228627
CUSIP67577R102
SectorLife Sciences - Pharmaceutical Preparations
Address15245 Shady Grove Road, Suite 455, Rockville, MD 20850
Source [EDGAR]
CIK Filing 2011 - 2025
[0001228627] 10-K
[0001228627] 10-Q
[0001228627] 3
[0001228627] 4
[0001228627] 5
[0001228627] 8-K
[0001228627] D
[0001228627] SC 13G
Form 13D/13G Filer Form 13D/13G Subject Filed % Owned
Richmond Brothers Inc Ocuphire Pharma Inc [2022-05-17] 5.84
Apexian Pharmaceuticals Inc Ocuphire Pharma Inc [2021-03-26] 7.136
Sooch Mina Ocuphire Pharma Inc [2021-03-17] 11.8
Altium Capital Management LP Ocuphire Pharma Inc [2020-11-16] 8.3
Richmond Brothers Inc Ocuphire Pharma Inc [2020-11-16] 1.0
Empery Asset Management LP Ocuphire Pharma Inc [2020-11-12] 7.58
Armistice Capital LLC Rexahn Pharmaceuticals Inc [2020-08-10] 1.0
Armistice Capital LLC Rexahn Pharmaceuticals Inc [2019-02-05] 4.99
Anson Funds Management LP Rexahn Pharmaceuticals Inc [2018-10-29] 5.1
CVI Investments Inc Rexahn Pharmaceuticals Inc [2018-10-26] 5.1
Sabby Management LLC Rexahn Pharmaceuticals Inc [2016-02-29] 4.89
Empery Asset Management LP Rexahn Pharmaceuticals Inc [2015-11-10] 8.44
Sabby Management LLC Rexahn Pharmaceuticals Inc [2012-12-04] 6.41
Form 3/4/5 Filer 2011 - 2025
Ocuphire Pharma, Inc.
Ainsworth Sean
Gallagher Cam
Benton Susan
Pepose Jay
Manuso James S J
Patel Ronil A.
Rodgers Richard J
Sooch Mina
Hoffmann Bernhard
Zaremba Rabourn Amy
Meyer Alan R
Brandt Peter C.
Beever Charles
Price Ben Gil
Sullivan Lara
Cheong Kwang Soo
Nolan Lisa
Benaim Ely
Swirsky Douglas J
Suzdak Peter David
Ahn Chang Ho
Carthy Mark
Jeong Tae Heum
McIntosh David M
Hwang Si Moon
Soni Rakesh
Kivel Richard
Form 13F Holdings
Firm Period DFND Voting Shares
Vanguard Group Inc [2023-03-31] SOLE 0.0 840,909.0
Rice Hall James & Associates LLC [2023-03-31] SOLE 744,029.0 809,117.0
MAI Capital Management [2023-03-31] SOLE 424,201.0 494,690.0
Richmond Brothers Inc [2023-03-31] SOLE 0.0 340,526.0
Renaissance Technologies LLC [2023-03-31] SOLE 43,100.0 189,969.0
Geode Capital Management LLC [2023-03-31] DFND 181,370.0 181,370.0
Knoll Capital Management, LLC [2023-03-31] SOLE 100,000.0 100,000.0
State Street Corp [2023-03-31] DFND 62,173.0 62,173.0
Diametric Capital LP [2023-03-31] DFND 55,648.0 55,648.0
BlackRock Inc. [2023-03-31] SOLE 52,201.0 52,201.0
Northern Trust Corp [2023-03-31] DFND 0.0 32,070.0
Morgan Stanley [2023-03-31] DFND 0.0 28,614.0
Trust Co of Toledo NA /OH/ [2023-03-31] SOLE 26,000.0 26,000.0
Dimensional Fund Advisors LP [2023-03-31] SOLE 21,190.0 21,190.0
Private Advisor Group LLC [2023-03-31] SOLE 10,000.0 20,000.0
Occudo Quantitative Strategies LP [2023-03-31] SOLE 19,623.0 19,623.0
Captrust Financial Advisors [2023-03-31] SOLE 19,501.0 19,501.0
Citadel Advisors LLC [2023-03-31] DFND 18,546.0 18,546.0
Legato Capital Management LLC [2023-03-31] OTR 0.0 16,456.0
CornerStone Capital Inc [2023-03-31] SOLE 16,357.0 16,357.0
Bank of New York Mellon Corp [2023-03-31] DFND 16,350.0 16,350.0
Bedel Financial Consulting Inc [2023-03-31] SOLE 0.0 15,000.0
Susquehanna International Group LLP [2023-03-31] DFND 14,751.0 14,751.0
Simplex Trading LLC [2023-03-31] SOLE 13,776.0 13,776.0
Stokes Family Office LLC [2023-03-31] SOLE 0.0 12,120.0
United Bank [2023-03-31] OTR 3,600.0 11,800.0
Lincoln National Corp [2023-03-31] SOLE 0.0 11,600.0
Kestra Private Wealth Services LLC [2023-03-31] SOLE 0.0 10,000.0
Vanguard Group Inc [2023-03-31] DFND 0.0 5,793.0
Dimensional Fund Advisors LP [2023-03-31] DFND 0.0 4,402.0
Prev | Page 108 | Next
Terms | Privacy | Guide
tony@aum13f.com